Table 1.
Drug | Species | Target | Direction | Location | Administration | Citation |
---|---|---|---|---|---|---|
Cocaine | Animal | G-CSF | ↑ | Peripheral/Central | Repeated | Calipari et al. (2018) |
Cocaine | Human | IL-10 | ↓ | Peripheral | Active users | Moreira et al. (2016) |
Cocaine | Human | IL-17 | ↓ | Peripheral | Abstinence | Maza-Quiroga et al., (2017) |
Cocaine | Human | IL-6 | ↓ | Peripheral | Acute | Halpern et al., (2003) |
Abstinence | Pedraz et al., (2015) | |||||
Cocaine | Human | IL-6 | ↑ | Peripheral | Active users | Levandowski et al., (2016) |
↓ | Moreira et al., (2016) | |||||
Cocaine | Human | MCP-1 | Peripheral | Acute | Gupta et al., (2018) | |
Abstinence | Pedraz et al., (2015) | |||||
Cocaine | Human | MIP-1α | ↓ | Peripheral | Abstinence | Maza-Quiroga et al., (2017) |
Cocaine | Animal | SDF-1 | ↑ | Peripheral | Repeated | Araos et al., (2015) |
Cocaine | Human | TGF-α | ↓ | Peripheral | Abstinence | Maza-Quiroga et al., 20170 |
Cocaine | Animal | TNF-α | ↑ | Central | Repeated | Lewitus et al., (2016) |
Cocaine | Human | TNF-α | ↓ | Peripheral | Abstinence | Pedraz et al., (2015) |
Opioid | Animal | ECP | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | Fractalkine | ↑ | Central | Repeated | Hutchinson et al., (2008a) |
Opioid | Animal | GRO/KC | ↑ | Central | Repeated | Hutchinson et al., (2008a) |
Opioid | Animal | IFN-γ | ↑ | Peripheral/Central | Acute | Pacifici et al., (2000) |
Schwarz et al., (2011) | ||||||
Opioid | Animal | IL-10 | ↑ | Peripheral/Central | Repeated | Hutchinson et al., (2008a) |
↑ | Acute | Schwarz et al., (2011) | ||||
Opioid | Animal | IL-17A | Peripheral | Chronic | Meng et al., (2015) | |
Opioid | Animal | IL-1β | ↑ | Peripheral/Central | Acute | Eidson et al., (2016) |
Repeated | Hutchinson et al., (2008a) | |||||
Chronic | Johnston et al., (2004) | |||||
Chronic | Kang et al., (2017) | |||||
Repeated | Raghavendra et al., (2002) | |||||
Opioid | Animal | IL-2 | ↓ | Peripheral | Acute | Lysle et al., (1993) |
Opioid | Animal | IL-2 | ↑ | Peripheral | Acute | Pacifici et al., (2000) |
Opioid | Animal | IL-6 | Peripheral/Central | Repeated | Hutchinson et al., (2008a) | |
Chronic | Johnston et al., (2004) | |||||
Chronic | Meng et al., (2015) | |||||
Repeated | Raghavendra et al., (2002) | |||||
Chronic | Zhang et al., (2011) | |||||
Opioid | Animal | MCP-1 | ↑ | Central | Repeated | Hutchinson et al., (2008a) |
Opioid | Animal | MCP-5 | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | MIG | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | MIP-1α | ↑ | Central | Repeated | Hutchinson et al., (2008a,b) |
Opioid | Animal | MIP-1β | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | RANTES | ↑ | Central | Repeated | Campbell et al., (2013) |
Opioid | Animal | TARC | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | TECK | ↑ | Central | Acute | Schwarz et al., (2011) |
Opioid | Animal | TNF-α | ↑ | Peripheral/Central | Chronic | Johnston et al., (2004) |
Repeated | Niwa et al., (2007) | |||||
Acute | Pacifici et al., (2000) | |||||
Repeated | Raghavendra et al., (2002) | |||||
Chronic | Zhang et al., (2011) |
A number of cytokines and chemokines have been shown to be differentially regulated by stimulants or opioids in the periphery or in the CNS of human subjects and animal models. This table outlines the known changes in these factors by substance, location, direction and subjects.